Lion TCR is VC-Backed and has raised funding across Series B and Series A rounds. It is backed by Lion Therapeutics and Skyline Capital Investment.
Alternatives.pe tracks Lion TCR's funding history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-08-18
Browse all uploaded documents here
Extracted Financial Statement 2023
Extracted Financial Statement
ViewExtracted Financial Statement 2022
Extracted Financial Statement
ViewExplore the latest updates and insights
Lion TCR secures $40M in Series B2 financing led by Chinese investors
Series B2 Round
A view of the number of employees over time
Extracted Financial Statement 2021
Extracted Financial Statement
ViewExtracted Financial Statement 2020
Extracted Financial Statement
ViewKey members of the management team